Home » Topics » Conferences

Conferences
RSS

Senju describes new calpain inhibitor

April 10, 1997

FR-138104: a new D2 antagonist from Fujisawa

April 10, 1997

New bradykinin B2 antagonist from Fujisawa

April 10, 1997

Nigella sativa plant extract exerts antiangiogenic activity

April 8, 1997

PEG-rHuMGDF safe and effective for chemotherapy-induced thrombocytopenia

April 8, 1997

Perindopril accelerates endothelial regrowth in animal model

April 7, 1997

Antithrombotic effect of Yamanouchi's YM-337

April 3, 1997

New experimental data for TPO reported by Kirin Brewery

April 3, 1997

Hematoprotective effects of PEG-rHuMGDF in mice

April 3, 1997

E-456, a minimum functional fragment of thrombomodulin from Asahi Chemical

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...